Guesting on the Joint Dynamics podcast, Phil Newman discusses longevity tipping factors, new medicine and flipping the demographic pyramid.
Phil was delighted to be a visitor on the Joint Dynamics Podcast lately. In his podcast chat with Andrew Cox, knowledgeable private coach with the Hong Kong-based Joint Dynamics clinic, Phil shares his insider’s expertise and understanding on the quickly rising science of longevity, discussing the right way to stay more healthy, longer, and the way folks can take part within the rising longevity financial system. Additionally coated within the podcast are a few of Phil’s private experiences, his view of business traits, and what his take is on slowing the speed of getting older.
Phil Newman on…
What’s longevity?
The plasticity of getting older and the power to manage getting older are beginning to come into public consciousness – it’s about extending healthspan and compressing the morbidity interval and that’s nice as a result of we’re all interested by folks residing longer lives, however frankly, crucial factor is that authorities and healthcare programs sit up and perceive what’s occurring on this area as effectively. They’ve acquired this gnarly macroeconomic challenge which is going on in all societies around the globe, which is that you just’re getting fewer youthful tax earners and also you’re getting increasingly more older folks residing in retirement and making a healthcare burden. The US spends $3 trillion every year on healthcare, 90% of which is for age-related illnesses.
Longevity just isn’t about simply residing lengthy; no person desires to stay to 125 in a care dwelling. It’s about extending healthspan and compressing the morbidity interval to essentially the most minimal period of time attainable. The purpose is to provide folks and healthcare programs the advantage of an absence of illness. The healthcare system is presently a sick care system – you go while you’re damaged. The pivot to preventative medicines is going on, supported by governments. We’ve seen this with GLP-1 medicine for weight reduction. Think about what’s going to occur when there’s a drug for mitigating age-related illnesses at a complete physique systemic stage. When it lands, it’s going to be mega.
Trying to the long run
The longevity business is attracting billions of {dollars} yearly, creating future therapeutics that would prolong wholesome human lifespans. Ideas like mobile reprogramming intention to rewind the age of cells, probably rejuvenating all the physique somewhat than simply particular elements. This might maintain folks of their 30s biologically for so long as they will entry these therapies, opening discussions about longevity escape velocity and even immortality.
This intersection of historic biology and fashionable AI is accelerating discovery in therapeutics. AI is producing quite a few theoretical targets, making a downstream problem to validate and produce these therapies to market. Regardless of the velocity of AI-driven discovery, the required levels of scientific improvement, which might take as much as 10 years, can’t be bypassed.
The convergence of longevity and area industries is fascinating. Area offers a novel analysis platform as astronauts age sooner in area, making it ultimate for finding out longevity therapeutics. Moreover, the decline in beginning charges and the necessity for a sustainable planet stuffed with wholesome folks ties into the idea of off-planet colonies, highlighting the significance of longevity analysis for future area journey.
Finally, whereas the potential of AI and new applied sciences in discovering and creating new therapies is immense, the stringent processes and issues in scientific improvement guarantee security and efficacy, paving the way in which for a future the place people can stay longer, more healthy lives.
